FEB 2015 FDA inserts a partial hold on PBT2 . FEB 2016 NO...

FEB 2015 FDA inserts a partial hold on PBT2 .
FEB 2016 NO information
At the AGM shareholders were informed that an independent body will re trial canine toxicity experiments
now we told its internal with collaborators. Who are the collaborators? EMA FDA who?
AS these trails have already been completed once . WHAT is the approximate timeframe for a second completion? Without divulging sensitive information where is the correspondence? Where is any correspondence?
Regarding Huntington Disease Who are the selected National Authorities other than the EMA and FDA for the information regulatory package are
to be sent to? Why haven't human trials been done in Europe?
Where are the trials if any to be conducted?
As for PBT 434 when will the first in man studies be conducted 2016,17,18 ,19 or 2050 and where?
With approx. $12 million in expenses each year and according to accounts the balance at the end of June 2015 of $34mill
3 years of cash left, who will pay for a cash call at these near JUNK share price?
What is this public relations and marketing expense of $93000 when there is nothing to market. Is this a slash fund to complement the
$43000 travel expense? I try to understand the need to promote the Coy ...$93000 is a lot of drinks.
Does the company have a qualified secretary, no mention of the position or person in the half year report.
This company acts in a secretive and clandestine fashion offering shareholders little confidence in the management, by issuing repeated
regurgitated and rehashed reports that only driven a great little Australian company to near junk levels. This is not a reflection on the
researchers and their great work, but on censorship by a control freak.